Cargando…

A nanotherapeutic strategy to target drug‐tolerant cells and overcome EGFR tyrosine kinase inhibitor resistance in lung cancer

Detalles Bibliográficos
Autores principales:	Shaurova, Tatiana, Yan, Lingyue, Su, Yafei, Rich, Laurie James, Vincent‐Chong, Vui King, Calkins, Hannah, Pokharel, Saraswati, Petkovich, Martin, Seshadri, Mukund, Wu, Yun, Hershberger, Pamela Anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091104/ https://www.ncbi.nlm.nih.gov/pubmed/36691995 http://dx.doi.org/10.1002/cac2.12401

Ejemplares similares

Understanding Lineage Plasticity as a Path to Targeted Therapy Failure in EGFR-Mutant Non-small Cell Lung Cancer
por: Shaurova, Tatiana, et al.
Publicado: (2020)

Preclinical Prevention Trial of Calcitriol: Impact of Stage of Intervention and Duration of Treatment on Oral Carcinogenesis
por: Vincent-Chong, Vui King, et al.
Publicado: (2019)

Vitamin D3 Metabolites Demonstrate Prognostic Value in EGFR-Mutant Lung Adenocarcinoma and Can be Deployed to Oppose Acquired Therapeutic Resistance
por: Shaurova, Tatiana, et al.
Publicado: (2020)

Delivery of anti-microRNA-21 by lung-targeted liposomes for pulmonary fibrosis treatment
por: Yan, Lingyue, et al.
Publicado: (2023)

Development and Radiation Response Assessment in A Novel Syngeneic Mouse Model of Tongue Cancer: 2D Culture, 3D Organoids and Orthotopic Allografts
por: Vincent-Chong, Vui King, et al.
Publicado: (2020)

Adrenergic-Angiogenic Crosstalk in Head and Neck Cancer: Mechanisms and Therapeutic Implications
por: Vincent-Chong, Vui King, et al.
Publicado: (2021)

Nanotherapeutics Overcoming the Blood-Brain Barrier for Glioblastoma Treatment
por: Tang, Lin, et al.
Publicado: (2021)

Photoacoustic monitoring of tumor and normal tissue response to radiation
por: Rich, Laurie J., et al.
Publicado: (2016)

Ultrasound guided generation of PDOX models of adenoid cystic carcinoma
por: Seshadri, Mukund, et al.
Publicado: (2019)

Nanotherapeutic approaches to overcome distinct drug resistance barriers in models of breast cancer
por: Saha, Tanmoy, et al.
Publicado: (2021)

Emerging Nanotherapeutic Approaches to Overcome Drug Resistance in Cancers with Update on Clinical Trials
por: Bukhari, Syed Nasir Abbas
Publicado: (2022)

Depleting receptor tyrosine kinases EGFR and HER2 overcomes resistance to EGFR inhibitors in colorectal cancer
por: Yang, Lu, et al.
Publicado: (2022)

Linking ATP and allosteric sites to achieve superadditive binding with bivalent EGFR kinase inhibitors
por: Heppner, David, et al.
Publicado: (2023)

Nanotherapeutics to Modulate the Compromised Micro-Environment for Lung Cancers and Chronic Obstructive Pulmonary Disease
por: Seshadri, Dhruv R., et al.
Publicado: (2018)

Glycofullerenes as non-receptor tyrosine kinase inhibitors- towards better nanotherapeutics for pancreatic cancer treatment
por: Serda, Maciej, et al.
Publicado: (2020)

Advances in personalized nanotherapeutics
por: Kaushik, Ajeet, et al.
Publicado: (2017)

Polymeric nanomaterials for nanotherapeutics
por: Vasile, Cornelia
Publicado: (2018)

Targeted nanotherapeutics in cancer
por: Shiekh, Farooq A
Publicado: (2014)

Spatiotemporal Optoacoustic Mapping of Tumor Hemodynamics in a Clinically Relevant Orthotopic Rabbit Model of Head and Neck Cancer()
por: Rich, Laurie J., et al.
Publicado: (2017)

Overcoming EGFR T790M-based Tyrosine Kinase Inhibitor Resistance with an Allele-specific DNAzyme
por: Lai, Wei-Yun, et al.
Publicado: (2014)

Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management
por: Shyam Sunder, Sunitha, et al.
Publicado: (2023)

Photoacoustic Imaging as an Early Biomarker of Radio Therapeutic Efficacy in Head and Neck Cancer
por: Rich, Laurie. J., et al.
Publicado: (2018)

Nanotherapeutics for treating coronavirus diseases
por: Gunathilake, Thennakoon M. Sampath U., et al.
Publicado: (2021)

Smart Nanotherapeutics and Lung Cancer
por: Doroudian, Mohammad, et al.
Publicado: (2021)

Nanotherapeutics: Engineering Cell Membrane‐Based Nanotherapeutics to Target Inflammation (Adv. Sci. 15/2019)
por: Yan, Huize, et al.
Publicado: (2019)

Mimicking the BIM BH3 domain overcomes resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer
por: Xia, Jinjing, et al.
Publicado: (2017)

Successful sequential tyrosine kinase inhibitors to overcome a rare compound of EGFR exon 18–18 and EGFR amplification: A case report
por: Wang, Pascal, et al.
Publicado: (2022)

Mechanisms and Implications of Dual-Acting Methotrexate in Folate-Targeted Nanotherapeutic Delivery
por: Wong, Pamela T., et al.
Publicado: (2015)

Peptide-siRNA nanotherapeutics in arthritis
por: Pham, Christine T.N., et al.
Publicado: (2015)

RNA Nanotherapeutics for the Amelioration of Astroglial Reactivity
por: Smith, Jayden A., et al.
Publicado: (2017)

Nanotherapeutics for Treatment of Pulmonary Arterial Hypertension
por: Segura-Ibarra, Victor, et al.
Publicado: (2018)

Extracellular Vesicles as Nanotherapeutics for Parkinson’s Disease
por: Leggio, Loredana, et al.
Publicado: (2020)

Microglia-targeting nanotherapeutics for neurodegenerative diseases
por: Zhao, Nanxia, et al.
Publicado: (2020)

Recent Advances in Nanotherapeutics for Multiple Myeloma
por: Iannazzo, Daniela, et al.
Publicado: (2020)

Potential nanotherapeutic strategies for perioperative stroke
por: An, Jingyi, et al.
Publicado: (2022)

Editorial: Oral Nanotherapeutics for Colon Diseases
por: Duan, Lian, et al.
Publicado: (2021)

Nanotherapeutic Intervention in Photodynamic Therapy for Cancer
por: Itoo, Asif Mohd, et al.
Publicado: (2022)

Lipid-engineered nanotherapeutics for cancer management
por: Fernandez-Fernandez, Alicia, et al.
Publicado: (2023)

Recent Advances in Nanotherapeutics for Neurological Disorders
por: Vashist, Arti, et al.
Publicado: (2023)

Blockade of AXL activation overcomes acquired resistance to EGFR tyrosine kinase inhibition in non-small cell lung cancer
por: Wang, Feng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_po1id7dnpsleih9iip2b8oatb7